Ionis Pharmaceuticals IONS Unrecognized Tax Benefits - Impacting Effective Tax Rate
Unrecognized Tax Benefits - Impacting Effective Tax Rate at other companies
Other financials
Where this comes from
Reported directly by Ionis Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate.
The official record: Ionis Pharmaceuticals’s 10-K, filed February 26, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ionis Pharmaceuticals's unrecognized tax benefits - impacting effective tax rate.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ionis Pharmaceuticals's unrecognized tax benefits - impacting effective tax rate?
- Ionis Pharmaceuticals (IONS) reported unrecognized tax benefits - impacting effective tax rate of $200K in Q4 2025.
- What is the long-term trend for Ionis Pharmaceuticals's unrecognized tax benefits - impacting effective tax rate?
- Over 2 years (2023 to 2025), Ionis Pharmaceuticals's unrecognized tax benefits - impacting effective tax rate has grown at a -18.4% compound annual growth rate (CAGR), from $300K to $200K.
- What does unrecognized tax benefits - impacting effective tax rate mean?
- The amount of uncertain tax savings that would change the company's tax rate if they were disallowed.
- How do you interpret unrecognized tax benefits - impacting effective tax rate?
- A higher value indicates greater potential volatility in the effective tax rate due to tax audit outcomes.
- How does unrecognized tax benefits - impacting effective tax rate compare across companies?
- A key metric for analysts assessing the sustainability of a company's effective tax rate.